Kenvue Inc.Kenvue Inc.Kenvue Inc.

Kenvue Inc.

No trades
See on Supercharts

Key facts today

The FDA will remove oral phenylephrine from OTC nasal decongestants, impacting Kenvue Inc.'s Tylenol products, as it determined that oral phenylephrine does not effectively relieve nasal congestion.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪45.40 B‬USD
0.56USD
‪1.66 B‬USD
‪15.44 B‬USD
‪1.91 B‬
Beta (1Y)
0.07
Employees (FY)
‪22 K‬
Change (1Y)
−200 −0.90%
Revenue / Employee (1Y)
‪701.95 K‬USD
Net income / Employee (1Y)
‪75.64 K‬USD

About Kenvue Inc.


CEO
Thibaut Mongon
Website
Headquarters
Skillman
FIGI
BBG01C79X561
Kenvue, Inc. is a consumer health company. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment focuses on oral care, baby care, women's health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
KNVU5672490
Kenvue Inc. 5.2% 22-MAR-2063
Yield to maturity
5.33%
Maturity date
Mar 22, 2063
KNVU5670795
Kenvue Inc. 5.05% 22-MAR-2053
Yield to maturity
5.17%
Maturity date
Mar 22, 2053
KNVU5672577
Kenvue Inc. 5.1% 22-MAR-2043
Yield to maturity
5.15%
Maturity date
Mar 22, 2043
KNVU5674332
Kenvue Inc. 5.5% 22-MAR-2025
Yield to maturity
5.15%
Maturity date
Mar 22, 2025
KNVU5670790
Kenvue Inc. 4.9% 22-MAR-2033
Yield to maturity
4.85%
Maturity date
Mar 22, 2033
KNVU5674333
Kenvue Inc. 5.0% 22-MAR-2030
Yield to maturity
4.61%
Maturity date
Mar 22, 2030
KNVU5673074
Kenvue Inc. 5.35% 22-MAR-2026
Yield to maturity
4.50%
Maturity date
Mar 22, 2026
KNVU5673058
Kenvue Inc. 5.05% 22-MAR-2028
Yield to maturity
4.42%
Maturity date
Mar 22, 2028

Explore more bonds 

Frequently Asked Questions


The current price of KVUE is 23.68 USD — it has increased by 3.09% in the past 24 hours. Watch Kenvue Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Kenvue Inc. stocks are traded under the ticker KVUE.
KVUE stock has risen by 3.59% compared to the previous week, the month change is a 8.52% rise, over the last year Kenvue Inc. has showed a 22.82% increase.
We've gathered analysts' opinions on Kenvue Inc. future price: according to them, KVUE price has a max estimate of 27.00 USD and a min estimate of 21.00 USD. Watch KVUE chart and read a more detailed Kenvue Inc. stock forecast: see what analysts think of Kenvue Inc. and suggest that you do with its stocks.
KVUE reached its all-time high on May 15, 2023 with the price of 27.80 USD, and its all-time low was 17.67 USD and was reached on Jul 11, 2024. View more price dynamics on KVUE chart.
See other stocks reaching their highest and lowest prices.
KVUE stock is 3.85% volatile and has beta coefficient of 0.07. Track Kenvue Inc. stock price on the chart and check out the list of the most volatile stocks — is Kenvue Inc. there?
Today Kenvue Inc. has the market capitalization of ‪45.35 B‬, it has decreased by −0.35% over the last week.
Yes, you can track Kenvue Inc. financials in yearly and quarterly reports right on TradingView.
Kenvue Inc. is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
KVUE earnings for the last quarter are 0.28 USD per share, whereas the estimation was 0.27 USD resulting in a 2.82% surprise. The estimated earnings for the next quarter are 0.26 USD per share. See more details about Kenvue Inc. earnings.
Kenvue Inc. revenue for the last quarter amounts to ‪3.90 B‬ USD, despite the estimated figure of ‪3.92 B‬ USD. In the next quarter, revenue is expected to reach ‪3.79 B‬ USD.
KVUE net income for the last quarter is ‪383.00 M‬ USD, while the quarter before that showed ‪58.00 M‬ USD of net income which accounts for 560.34% change. Track more Kenvue Inc. financial stats to get the full picture.
Yes, KVUE dividends are paid quarterly. The last dividend per share was 0.20 USD. As of today, Dividend Yield (TTM)% is 3.40%. Tracking Kenvue Inc. dividends might help you take more informed decisions.
As of Nov 9, 2024, the company has ‪22.00 K‬ employees. See our rating of the largest employees — is Kenvue Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kenvue Inc. EBITDA is ‪3.49 B‬ USD, and current EBITDA margin is 23.09%. See more stats in Kenvue Inc. financial statements.
Like other stocks, KVUE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kenvue Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kenvue Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kenvue Inc. stock shows the buy signal. See more of Kenvue Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.